Alphatec Holdings shares are trading higher after the company issued preliminary Q4, FY23 and FY24 revenue guidance above estimates. The company executed a strategic partnership agreement with Aclarion to advance the commercialization of Nociscan.
Benzinga Newsdesk - Jan 8, 2024, 12:43PM